Xconomy: Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments
Summary
Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments (Page 2 of 2) some important allies.Pellini was formerly the president and chief operating officer of Clarient, a leading developer of cancer diagnostics that was acquired by General Electric (NYSE: GE) in 2010.It’s a taste of things to come in our industry.” Foundation Medicine is working quickly to bring its technology into mainstream medical practice.Next year, the company plans to market a test that will help physicians determine the best treatments and clinical trial options for each patient, based on his or her cancer’s unique genetic blueprint.The knowledge the company amasses about alterations in cancer genes will be reported on an interactive Web site, which customers can use to locate trials for their patients and stay on top of the latest developments in oncology treatment.